Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun;11(2):283-300.
doi: 10.1007/s13668-022-00410-7. Epub 2022 Mar 25.

Supplementation of Infant Formula and Neurodevelopmental Outcomes: a Systematic Review

Victoria Arija  1   2   3 , Cristina Jardí  1   2   3 , Cristina Bedmar  1   2   3 , Andrés Díaz  1   2   3 , Lucía Iglesias-Vázquez  1   2   3 , Josefa Canals  4   5   6
Affiliations

Supplementation of Infant Formula and Neurodevelopmental Outcomes: a Systematic Review

Victoria Arija et al. Curr Nutr Rep. 2022 Jun.

Abstract

Purpose of the review: The aim is to examine data from clinical trials and prospective longitudinal studies that evaluate the effect of infant formula supplements on the cognitive function of children.

Recent findings: A total of 300 articles from 2000 to 2021 were selected. The most researched IF supplements were initially long-chain polyunsaturated fatty acids (LC-PUFA), some proteins and, recently, milk fat globule membrane (MFGM). Supplementation of IF with LC-PUFA led to some positive effects on specific cognitive functions or no effect; however, there was no consistent benefit for cognitive function. Modifying the amount of proteins did not affect the children's neuropsychological tests. Supplementation of IF with MFGM and its components had beneficial effects on child cognitive development in the short term, but no effect was observed in the long term. Further studies are needed to confirm the safety of supplementation on the development of cognitive function in children fed with infant formula.

Keywords: Infant formula; Infant neurodevelopment; Infant nutrition; Nutritional supplementation.

PubMed Disclaimer

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
    1. Villar M, Santa-Marina L, Murcia M, Amiano P, Gimeno S, Ballester F, Julvez J, Romaguera D, Fernández-Somoano A, Tardón A, Ibarluzea J. Social factors associated with non-initiation and cessation of predominant breastfeeding in a mother–child cohort in Spain. Matern Child Health J. 2018;22(5):725–34. https://doi.org/10.1007/s10995-018-2441-1 . - DOI - PubMed
    1. de Graff-Peter VB, Hadders-Algra M. Ontogeny of the human central nervous system: what is happening when? Early Hum Dev. 2006;82(4):257–66. https://doi.org/10.1016/j.earlhumdev.2005.10.0.13 . - DOI
    1. Lemaire M, Huërou-Luron IL, Blat S. Effects of infant formula composicition on long-term metabolic health. J Dev Orig Health Dis. 2018;9(6):573–89. https://doi.org/10.1017/S2040174417000964 . - DOI - PubMed
    1. Martinez M. Tissue levels of polyunsaturated fatty acids during early human development. J Pediatr. 1992;120(4 Pt 2):S129–38. https://doi.org/10.1016/S00223476(05)81247-8 . - DOI - PubMed
    1. Brenna JT, Varamini B, Jensen RG, Diersen-Schade DA, Boettcher JA, Arterburn LM. Docosahexaenoic and arachidonic acid concentrations in human breast milk worldwide. Am J Clin Nutr. 2007;85(6):1457–64. https://doi.org/10.1093/ajcn/85.6.1457 . - DOI - PubMed

Publication types

Substances